Soleno Therapeutics Stock News & Updates
[WKN: A3DS0P | Symbol: SLNO]
Soleno Therapeutics
Analysts' Top 5 Price Targets of October 7, 2025
Soleno Therapeutics - The FDA Approval for Vykat XR Represents an Important Milestone!
Business drivers: Soleno Therapeutics (SLNO) specializes in the development of new therapies and medications...
Soleno Therapeutics - FDA Approval for Vykat XR Represents Significant Milestone!
Business drivers: Soleno Therapeutics (SLNO) specializes in the development of new therapies and medications...
Darvas Screening: AngloGold Ashanti, Palomar Holdings, Alignment Healthcare, and Soleno Therapeutics.
The NEO-DARVAS-STRATEGY is a remarkable trend-following approach based on a simple yet effective concept:...
Soleno Therapeutics: The biopharmaceutical company receives important FDA approval for a drug to treat a rare genetic disorder
Soleno is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases....
Soleno Therapeutics in our Pivotal Point Check: Stifel Sees "Blockbuster Opportunity" in the FDA Approval of Vykat XR for the Treatment of Prader-Willi Syndrome!
Soleno Therapeutics has achieved a milestone in the rare disease market. The treatment with Diazoxide-Choline...
- ‹
- 1
- ›